FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary by Paul, Stefan et al.
Eur Arch Otorhinolaryngol (2007) 264:189–195 
DOI 10.1007/s00405-006-0177-9
HEAD AND NECK
FDG PET and PET/CT for the detection of the primary tumour 
in patients with cervical non-squamous cell carcinoma metastasis 
of an unknown primary
Stefan A. M. Paul · Sandro J. Stoeckli ·
Gustav K. von Schulthess · Gerhard W. Goerres 
Received: 19 December 2005 / Accepted: 7 September 2006 / Published online: 3 October 2006
©  Springer-Verlag 2006
Abstract In patients with a neck metastasis from an
unknown primary with non-squamous cell cancer (non-
SCC) histology, the primary is often located outside
the head and neck area. We retrospectively evaluated
326 patient records and found 14 patients with non-
SCC neck lymph node metastasis from an unknown
primary undergoing whole body F-18-Xuorodeoxyglu-
cose (FDG) positron emission tomography (PET) with
or without coregistered computed tomography (PET/
CT). The PET or PET/CT Wndings were veriWed by
pathological work-up, additional imaging tests, and
clinical follow-up. PET detected pathological FDG
uptake suspicious for the primary in eight patients.
PET or PET/CT Wndings were true positive in seven
patients, true negative in 4, false positive in 1, and false
negative in two patients. In one patient PET/CT
revealed a synchronous ovarian carcinoma. The results
suggest that whole body imaging with FDG PET and
PET/CT can be useful to identify unknown primaries
of non-SCC origin. However, the work-up of patients
undergoing PET or PET/CT in our study was very het-
erogeneous and the primary was more likely found in
patients without extensive imaging before PET scan-
ning. Further studies should evaluate if the histology of
a neck nodal metastasis should inXuence the choice of
the imaging method and the role of PET and PET/CT
imaging for the work up of patients with a non-SCC
neck lymph node metastasis of an unknown primary.
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Introduction
Recent reports suggest that positron emission tomog-
raphy (PET) with F-18-Xuorodeoxyglucose (FDG) can
successfully be used for the identiWcation of the pri-
mary site in patients with a neck lymph node metastasis
from an unknown primary tumour [1–8]. The primary
tumour is usually found in the upper aero-digestive
tract. In patients with squamous cell cancer histology
the primary is often located in the tonsils or in areas
diYcult to inspect clinically, such as the pyriform sinus
or the nasopharynx [9, 10].
The primary can also be in the thorax and in the gas-
tro-intestinal or urogenital tracts, if the histology of the
cervical metastasis shows an adenocarcinoma [11]. The
pathologic diagnosis of adenocarcinoma is usually
based on the identiWcation of glandular structures that
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190 Eur Arch Otorhinolaryngol (2007) 264:189–195are formed by the neoplastic cells. Poorly diVerenti-
ated adenocarcinoma and poorly diVerentiated carci-
noma can be seen as descriptions of the same spectrum
of histologic appearance with carcinoma cells showing
a lesser degree of glandular diVerentiation. However, a
subset of patients with poorly diVerentiated adenocar-
cinoma may be distinctive in their tumour biology and
responsiveness to systemic chemotherapy (Hainsworth
and Greco, http://www.uptodate.com).
The biopsy material should be carefully evaluated and
instead of material obtained by Wne needle aspiration an
adequate biopsy specimen is preferred. Histological
work-up comprises immunohistochemical techniques to
better describe the potential origin of the primary and
can be complemented by electron microscopy, chromo-
some analysis, and gene micro array analysis.
Additionally, it has been suggested that involvement
of supraclavicular and low cervical lymph nodes are sus-
picious for a primary in the chest or abdomen, and are
associated with a poorer prognosis than lymph node
metastases of the upper neck levels [12, 13]. As the
search for the primary in patients with a neck metastasis
of non-squamous cell cancer (non-SCC) histology should
not be limited to the head and neck area, only, the use of
whole body imaging for further work-up, such as FDG
PET, seems beneWcial. A previous study suggested a low
clinical impact of FDG PET in patients undergoing
extensive work-up with panendoscopy for a neck metas-
tasis of squamous cell cancer histology before PET or
PET/CT scanning [14]. This recent work stressed the
importance of deWning the work-up before PET scan-
ning, since it is more likely to detect an unknown primary
the less is done as routine clinical work-up.
In our hospital routine work-up of patients with a
lymph node metastasis from a squamous cell carci-
noma consists of a thorough physical examination
including transnasal Wbre-endoscopy of the nasal cav-
ity, the nasopharynx, oropharynx, hypopharynx and
larynx, contrast-enhanced high-resolution computed
tomography (CT) or contrast-enhanced magnetic reso-
nance imaging (MRI) of the neck, and chest X-ray in
the postero-anterior and lateral views. Furthermore,
patients undergo tonsillectomy of the ipsilateral side if
no other primary tumour is detected during panendos-
copy under general anaesthesia. Panendoscopy consist
of rigid esophagoscopy, tracheobronchoscopy, hypo-
pharyngoscopy, laryngoscopy and inspection and pal-
pation of the oropharynx and oral cavity. The nasal
cavity and the nasopharynx are assessed through trans-
nasal rigid endoscopy with 0 and 30° endoscopes. Biop-
sies are only taken from suspicious mucosal areas and
no random biopsies neither in the nasopharynx nor in
the base of tongue are taken. Usually, PET or PET/CT
is acquired after this extensive work-up when all other
methods failed to Wnd the primary.
In patients with a non-SCC histology the work-up is
less standardized, but a similar work-up is done in most
patients to evaluate the upper aero-digestive tract. CT
of the chest and abdomen as well as clinical evaluation
with pelvic examination in women and prostate evalua-
tion in men is often performed, additionally. Proce-
dures such as endoscopic gastrointestinal evaluation
may complement the work-up. However, the role of
PET and PET/CT is less deWned in these patients.
Although recommendations exist how to evaluate
patients with an unknown primary site of a metastasis
from an adenocarcinoma or poorly diVerentiated neo-
plasm, no guideline exists on how to use the various
imaging methods in a deWned algorithm. Furthermore,
the inXuence of the histology and the level of the
lymph node metastasis in the neck on the choice of the
imaging method is not well deWned.
The purpose of this retrospective study was to evalu-
ate the use of whole body PET and PET/CT to identify
primaries outside the head and neck area in patients
with a neck lymph node metastasis of non-SCC origin.
Patients and methods
The records of all patients undergoing FDG PET or
PET/CT at the Division of Nuclear Medicine of the
University Hospital Zurich between January 1999 and
April 2006 were retrospectively reviewed. This review
was done in accordance with the guidelines of the local
ethics committee and for this retrospective analysis no
informed signed consent of the patients was necessary.
Only data of patients with cytologically/histologically
proven cervical lymph node metastases of a non-SCC
unknown primary was selected for this evaluation. The
Wndings of the clinical evaluation and imaging includ-
ing at least a chest X-ray was available in all patients.
PET or PET/CT scanning was done in these patients as
part of the work-up before or after imaging with mor-
phological methods (ultrasound, CT, MRI) of the head
and neck area, thorax, and abdomen. In all patients
with additional CT and MRI studies these structural
imaging tests were acquired using standard protocols
with contrast enhancement.
Prior to PET or PET/CT scanning the patients fasted
for at least 4 h. A standard activity of 370 MBq was
injected intravenously approximately 60 min prior to the
examination. All whole body PET and PET/CT scans
were acquired in supine position in a 2D mode using an
acquisition time of 4 min for the emission scan on a
Advance PET scanner or a Discovery LS PET/CT123
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USA). For attenuation correction either the built-in
transmission source was used on the PET only device or
the CT data on the combined scanner. The CT scan was
acquired with the built-in multislice detector CT scanner
(140 kV, 40 mAs, pitch 6) and without intravenous con-
trast injection. The CT acquisition as well as PET images
covered the whole body from the head to the pelvic
Xoor. Images were reconstructed using a standard itera-
tive algorithm (ordered subset expectation maximiza-
tion algorithm, OSEM; 28 subsets, two iterative steps).
The acquired images were viewed with software provid-
ing multiplanar reformatted images of PET alone or of
PET, CT and fused data with linked cursors (eNtegra
3.0215; GE Medical Systems, Waukesha, USA).
In patients undergoing PET/CT scanning areas with
increased FDG uptake guided the further search for
pathologies visible on the CT scan. The non-contrast
enhanced CT data of PET/CT scans were not sepa-
rately evaluated. All PET and PET/CT images were re-
evaluated by two experienced readers in consensus.
They knew that the patients had neck lymph node
metastasis of an unknown primary and were blinded
for the results of other imaging tests.
In all patients with imaging Wndings suggesting a pri-
mary lesion, histological conWrmation or cytological
work-up was available. In patients without suspicious
PET Wndings the clinical follow-up and the results of
additional imaging tests served as the standard of
reference.
Results
We evaluated the records of 326 consecutive patients
examined for neck lymph node metastases of an
unknown primary. Most patients underwent PET or
PET/CT for a neck metastasis of an unknown primary
cancer with squamous cell carcinoma histology. Only 14
patients (4.3%; 5 women and 9 men) with a mean age of
63.2 years (range 29–85 years) underwent PET or PET/
CT for an unknown primary with non-SCC histology.
In all patients at least information on physical exam-
ination, chest X-ray, and results of Wne needle biopsy/
histology of the neck lymph node was available before
scanning. The result of cytology or histology of the
neck metastases was adenocarcinoma and undiVerenti-
ated adenocarcinoma (n = 9), undiVerentiated carci-
noma (n = 3), undiVerentiated neuroendocrine tumour
(n = 1) and low-grade sarcoma (n = 1) (Table 1).
There were six in-patients and eight out-patients
undergoing PET or PET/CT scanning (Table 1). The six
in-patients (patient 3, 4, 7, 12, 13, 14; Table 1) were send
for scanning either from the Department of Otorhino-
laryngology, Head and Neck Surgery (patient 3, 4, 12,
13), the Department of Dermatology (patient 7) or the
Department of Internal Medicine (patient 14). CT/MRI
of the head and neck area was available in 5 and CT of
the thorax and/or abdomen or ultrasound of the abdo-
men in four patients before PET or PET/CT scanning.
Histology was always available in our in-patients. How-
ever, the clinical and imaging work-up before sending
the patient to PET or PET/CT diVered largely between
the referring physicians. In contrast, the diagnosis of a
lymph node metastasis of non-SCC origin was based on
Wne needle aspiration in six out of eight out-patients
(patient 1, 2, 6, 8, 9, 10; Table 1). In four of the eight out-
patients a CT or MRI of the head and neck area was
available and in three out-patients a CT of the thorax
and/or abdomen or an ultrasound of the abdomen was
done before PET or PET/CT scanning.
In patients 3, 6, 8, 9, and 11 lymph node involvement
was described in areas below the level of the cricoid
cartilage (Level IV and lower part of Level V including
the supraclavicular area). In all other patients lymph
nodes were identiWed in levels I through III and upper
region of Level V.
PET suggested a primary tumour in eight patients
(patient 1, 3, 4, 5, 6, 8, 10, 12; Table 1). An example of a
patient with a lung tumour with positive PET/CT Wnd-
ings but Wrst missed on conventional chest X-ray is shown
in Fig. 1. In seven of eight examinations the PET Wndings
were true positive and in one patient false positive
(patient 6). All positive PET Wndings were conWrmed by
histology of the primary lesion, except in patient 3 where
the Wnal diagnosis of an adenocarcinoma in the left lung
was based on the evaluation of pleural eVusion. In
patient 6 PET suggested an esophageal carcinoma, but
endoscopy with biopsy revealed inXammatory changes
with hyperkeratosis and no evidence of cancer. During a
follow-up of 11 months the primary was not found in this
patient, but additional metastases were identiWed.
In four patients PET was true negative (patient 7,
9, 11, 13) and in two patients false negative (patient 2
and 14). In 6 patients (patient 2, 7, 9, 11, 13, 14) PET
did not suspect a primary, although in-patient 13 a
second primary was suggested. Both, the neck lymph
node metastasis and the ovarian cancer were surgi-
cally resected. In this patient a secondary adenocarci-
noma of the right ovary (FIGO IIIb) was found at
PET/CT with a diVerent histological appearance than
the neck lymph node metastasis (Fig. 2). The primary
was not identiWed during a 2 years clinical follow-up
using addditional imaging with CT of the neck, thorax
and abdomen, as well as mammography and regular
gynaecological controls, and PET/CT scanning123
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Eur Arch Otorhinolaryngol (2007) 264:189–195 193(8 months after the Wrst PET/CT scan). In patient 7, 9,
and 11 the primary was not found during the follow-
up of at least one year (as reported by the referring
physician).
Based on these numbers the sensitivity, speciWcity,
and accuracy of PET was 77.8, 80.0, and 78.6%. The
positive and negative predictive values were 87.5 and
66.7%, respectively.
Fig. 1 Coronal maximum 
intensity projection (MIP) im-
age and transverse PET, CT 
and coregistered PET/CT im-
ages of a 72-year-old male pa-
tient (patient 12) with a neck 
lymph node metastasis at the 
left Level II (short arrow). 
PET revealed intense FDG 
uptake in a primary (black 
and white arrowheads) in the 
right lung. Lymph node 
metastases are found in the 
mediastinum and an addi-
tional intrapulmonary metas-
tasis in the right lower lobe 
(long arrow). The lung lesions 
were not identiWed on conven-
tional chest X-ray acquired in 
posterior–anterior projec-
tion. The Wnal diagnosis was 
adenocarcinoma of the lung. 
The black line indicates the 
level of the transverse sections
Fig. 2 Coronal maximum intensity projection (MIP) image and
transverse PET, CT and coregistered PET/CT images of a 48-
year-old female patient (patient 13) with a neck lymph node
metastasis (2.5 cm) at Level II under the strenocleidomastoid
muscle. PET revealed low to moderate FDG uptake in the lymph
node, which was enlarged on CT images (black and white arrow-
heads). A second lesion with low to moderate FDG uptake is
visible adjacent to the bladder corresponding to an enlarged ova-
ry on CT images (black and white arrows). The Wnal diagnosis was
an adenocarcinoma of the ovary (FIGO IIIb) as an incidental syn-
chronous tumour, but the primary responsible for the lymph node
metastasis was not found during 2 years of clinical follow-up and
additional PET/CT scanning (after 8 months). The transverse
sections are done at the level of the arrow/arrowhead123
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The results of this study conWrm previous observations
that PET with FDG is able to identify the primary
tumour in patients with a neck lymph node metastasis
[1–8]. In this study FDG PET and PET/CT had a mod-
erate sensitivity and speciWcity of 77.8 and 80.0%. The
whole body imaging approach used in our patients
allowed for the identiWcation of Wve malignancies
located in the chest and one incidentally found second-
ary gynaecological tumour. These results support the
view that patients with non-SCC histology and neck
lymph node involvement have a relatively high proba-
bility of a primary in the chest or abdomen. Therefore,
we suggest to acquire PET and PET/CT scans using a
whole body imaging protocol.
The histology of the primary may inXuence FDG
uptake and the visibility of a lesion on PET images.
FDG uptake was very variable as shown for example
in-patient 12 with an adenocarcinoma of the lung and a
very intense uptake (Fig. 1) and in patient 13 with only
low to moderate uptake in an ovarian adenocarcinoma
(Fig. 2). In all patients with adenocarcinoma of the
lung (patient 3, 4, 8, 12) the primary was seen with
PET. Furthermore, PET detected a small cell lung can-
cer (patient 5; histology of a low diVerentiated neuro-
endocrine carcinoma). Schumacher et al. [15]
suggested FDG PET to be of potential use as a simpli-
Wed staging tool for small cell lung cancer. In another
patient with metastasis from an adenocarcinoma
(patient 6), PET did not detect the primary but was
false positive due to oesophageal inXammatory
changes with hyperkeratosis. It is well known that
inXammatory cells in acute and chronic inXammation
take up FDG.
In four patients the primary was identiWed in the
head and neck area (patient 1, 2, 10, 14). In two of these
patients the primary was located in the salivary glands.
In a recent work it has been shown that FDG PET can
have a positive impact on the management of patients
with salivary gland malignancy at staging and in the
restaging situation [16]. In one patient a primary sar-
coma originating from the nerve sheath (patient 10) was
easily identiWed. It has previously been shown that sar-
comas of the head and neck usually have a high FDG
uptake [17, 18]. However, in patient 2 a superWcially
spreading melanoma of the skin of the scalp was not
detected, although melanoma regularly shows high
FDG uptake. This is because a small and superWcial
lesion can easily be missed due to the limited resolution
of the scanner. In this patient the Wne needle aspiration
biopsy of the lymph node revealed an undiVerentiated
carcinoma and only the histological work-up after surgi-
cal excision of the whole lymph node with immuno-his-
tochemical staining of the cells indicated the presence
of melanoma. This case underlines the importance of
obtaining high quality specimens for analysis since the
interpretation of cells obtained by Wne needle aspiration
may be more diYcult.
All patients with primaries within the head and neck
area had their lymph node metastasis above the level
of the cricoid. In contrast, only two of the Wve lung can-
cers metastasised to a neck lymph node below this
level. In Europe it is widely spread praxis that espe-
cially in patients with lymph node involvement below
the cricoid level a CT scan of the lung and mediastinum
should be obtained. This was done for example in
patient 3 before PET imaging, but interestingly, the in-
patients number 4, 12, and 13 had neck lymph nodes
involved above this level an did not undergo CT of the
thorax. In two of them this would clearly have allowed
the identiWcation of the primary lung tumour, thus
avoiding the need of additional PET imaging. Chest X-
ray alone is not as sensitive as CT scanning to identify
small lung lesions and peribronchial tumours at the
hilar level. Therefore, the praxis to only admit patients
to CT scanning when lymph node metastases are found
below the cricoid level has to be reconsidered, espe-
cially when non-SCC histology has been found.
The small patient group and the inconsistent imaging
work-up before PET or PET/CT scanning are major
drawbacks of our retrospective analysis. It clearly shows
that an algorithm is needed to deWne the use of imaging
tests during the clinical work-up of patients with cervical
non-SCC metastasis of an unknown primary. The pre-
PET evaluation of our patients varied widely between
in- and out-patients and in the in-patients referred from
diVerent departments.
On the other hand FDG PET or PET/CT could
serve as a screening test to assess the whole body in
patients with a suggested FDG avid histological type of
the neck lymph node metastasis. A positive PET result
could guide further diagnostic evaluation of the
patient. However, to date the role of PET or PET/CT
early in the work-up of patients with a neck lymph
node metastasis of an unknown non-SCC primary is
not clear. As an alternative approach contrast
enhanced computed tomography of the head and neck
area, thorax and abdomen is done in many centres for
whole body staging of patients with suspected malig-
nant disease. The role of MRI is less well deWned than
CT and MRI is mainly used for the work-up of the
head and neck area. In patient 14 a small adenocarci-
noma of the parotid gland was not detected with CT
and PET/CT imaging, but intra-operatively found
when removing further lymph nodes adjacent to the123
Eur Arch Otorhinolaryngol (2007) 264:189–195 195parotid gland. This underlines to use MRI with its well-
known high soft tissue contrast to evaluate the head
and neck area. Furthermore, it is well possible that this
lesion would have been identiWed with ultrasound.
However, structural imaging of the head and neck area
is not only used for staging purposes but also is needed
for correct treatment planning.
Our results question the use of chest X-rays in these
patients for staging purposes and detection of an
unknown primary. Additionally, it has previously been
suggested that screening imaging tests such as ultra-
sound of the abdomen or whole body skeletal scintigra-
phy have only a minor impact on identifying distant
metastases in patients with a cancer in the head and
neck area [19]. In contrast, whole body FDG PET or
PET/CT can add relevant information in patients under-
going staging with squamous cell carcinoma of the head
and neck. Additional suspicious lesions such as distant
metastases and secondary synchronous carcinomas can
be detected with PET/CT underlining the impact of
whole body imaging in patients with a pathology in the
head and neck area, although false positive Wndings may
decrease the performance of this imaging test [20].
In patients with a lymph node metastasis from a non-
SCC unknown primary, FDG PET and PET/CT is pref-
erably acquired as a whole body imaging method. Most
of the primaries in our patients were located in the tho-
rax and head and neck area. Therefore, a scrutinized
work-up of the head and neck area and thorax using
morphological imaging methods is to be recommended
in all patients with non-SCC histology of the lymph node
metastasis even when the involved lymph node is
located in a neck level above the cricoid. The informa-
tion on histology could inXuence the choice of the imag-
ing methods used for patient work-up. However, it
remains to be clariWed if PET could serve as a cost-eVec-
tive Wrst line method for whole body imaging of patients
with a non-SCC neck lymph node metastasis of an
unknown primary. Prospective studies in large patient
groups are needed to deWne the role of PET and PET/
CT imaging as part of the work up such patients.
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